1. Home
  2. XTNT

as of 11-28-2025 12:37pm EST

$0.56
$0.06
-10.16%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Chart Type:
Time Range:
Founded: N/A Country:
United States
United States
Employees: N/A City: BELGRADE
Market Cap: 91.3M IPO Year: N/A
Target Price: $1.50 AVG Volume (30 days): 316.0K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.01 EPS Growth: N/A
52 Week Low/High: $0.33 - $0.95 Next Earning Date: 11-10-2025
Revenue: $133,083,000 Revenue Growth: 16.88%
Revenue Growth (this year): 13.03% Revenue Growth (next year): -8.96%

AI-Powered XTNT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 66.67%
66.67%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: